These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 564952)

  • 1. Physical dependence to barbital compared to pentobarbital. III. Withdrawal characteristics.
    Boisse NR; Okamoto M
    J Pharmacol Exp Ther; 1978 Mar; 204(3):514-25. PubMed ID: 564952
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of ethanol and barbiturate physical dependence.
    Okamoto M; Hinman DJ; Aaronson LM
    J Pharmacol Exp Ther; 1981 Sep; 218(3):701-8. PubMed ID: 7196450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Physical dependence to barbital compared to pentobarbital. II. Tolerance characteristics.
    Boisse NR; Okamoto M
    J Pharmacol Exp Ther; 1978 Mar; 204(3):507-13. PubMed ID: 564951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physical dependence to barbital compared to pentobarbital. IV. Influence of elimination kinetics.
    Boisse NR; Okamoto M
    J Pharmacol Exp Ther; 1978 Mar; 204(3):526-40. PubMed ID: 564953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Physical dependence to barbital compared to pentobarbital. I. "Chronically equivalent" dosing method.
    Boisse NR; Okamoto M
    J Pharmacol Exp Ther; 1978 Mar; 204(3):497-506. PubMed ID: 564950
    [No Abstract]   [Full Text] [Related]  

  • 6. Barbiturate tolerance and physical dependence: contribution of pharmacological factors.
    Okamoto M
    NIDA Res Monogr; 1984; 54():333-47. PubMed ID: 6442760
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of individual variations in drug elimination kinetics for production of pentobarbital physical dependence.
    Okamoto M; Hinman DJ
    J Pharmacol Exp Ther; 1983 Jul; 226(1):52-6. PubMed ID: 6683313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characteristics of functional tolerance during barbiturate physical dependency production.
    Okamoto M; Boisse NR; Rosenberg HC; Rosen R
    J Pharmacol Exp Ther; 1978 Dec; 207(3):906-15. PubMed ID: 569696
    [No Abstract]   [Full Text] [Related]  

  • 9. Evaluation of anticonvulsants in barbiturate withdrawal.
    Okamoto M; Rosenberg HC; Boisse NR
    J Pharmacol Exp Ther; 1977 Aug; 202(2):479-89. PubMed ID: 560473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Physical dependence produced by long duration, low dose chronic barbital treatment.
    Okamoto M; Hinman DJ
    Subst Alcohol Actions Misuse; 1984; 5(2):97-103. PubMed ID: 6540898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Time course of audiogenic seizure susceptibility and plasma pentobarbital concentration during withdrawal.
    Buice RG; Bourn WM
    Res Commun Chem Pathol Pharmacol; 1978 Jan; 19(1):75-84. PubMed ID: 564537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological characterization of alcohol and barbital physical dependence in mice.
    Kaneto H; Kaneda H; Kawatani S
    Yakubutsu Seishin Kodo; 1987 Jun; 7(2):327-32. PubMed ID: 3687245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of inhibition in the spinal cord during barbiturate withdrawal.
    Rosenberg HC; Okamoto M
    J Pharmacol Exp Ther; 1978 Jun; 205(3):563-8. PubMed ID: 566321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differentiation of alcohol and barbital physical dependence.
    Kaneto H; Kawatani S; Kaneda H
    Yakubutsu Seishin Kodo; 1986 Jun; 6(2):267-73. PubMed ID: 3776353
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Osmotic minipumps for administration of barbital to mice: demonstration of functional tolerance and physical dependence.
    Siew C; Goldstein DB
    J Pharmacol Exp Ther; 1978 Mar; 204(3):541-6. PubMed ID: 564954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Sex differences in the physical dependence on barbital in rats].
    Suzuki T; Koike Y; Yoshii T; Yanaura S
    Yakubutsu Seishin Kodo; 1986 Dec; 6(4):373-80. PubMed ID: 3825311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sleep patterns in cats during chronic low-dose barbiturate treatment and withdrawal.
    Hinman DJ; Okamoto M
    Sleep; 1984; 7(1):69-76. PubMed ID: 6538986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of dosing frequency on the development of physical dependence and tolerance to pentobarbital.
    Okamoto M; Rao S; Walewski JL
    J Pharmacol Exp Ther; 1986 Sep; 238(3):1004-8. PubMed ID: 3746655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Demonstration of neurochemical tolerance following chronic barbital treatment.
    Lane SJ; Morgan WW
    Neurobehav Toxicol Teratol; 1985; 7(2):195-7. PubMed ID: 2987720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of propranolol on barbital dependence formation and withdrawal signs.
    Tagashira E; Hiramori T; Urano T; Nakao K; Yanaura S
    Jpn J Pharmacol; 1983 Feb; 33(1):133-43. PubMed ID: 6683767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.